Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

Xo-Motion R Exoskeleton in SCI-Adoption Study

A legfontosabb adatok

Ki végzi
University of Alberta
Hol
Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
16 fő, tervezett
Kezdés
2027. márc. 1.
Várható befejezés
2028. szept.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • XoMotionR- assisted locomotor training
A regiszteradat frissítve
2026. szeptember 16.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a spinal cord injury who want to walk better, using the XoMotion-R self-balancing exoskeleton (a robotic suit for the legs) in rehabilitation.

Életkor
18 Years and older
Nem
All
A betegség stádiuma
Spinal cord injury, including neck (cervical) injuries. Inpatients: AIS C or D. Outpatients: AIS B to D. AIS is a scale of how complete the injury is.
Biomarker vagy leletérték
Inpatients must not yet walk, with a predicted chance of walking on their own 1 year after injury above 50%. Outpatients must have a goal of better walking that the XoMotion can help reach.

A részvétel fő kizáró okai

  • Complete spinal cord injury (AIS A)

A regiszter feltételei, szó szerint

Mind a 4 feltétel megnézéseKevesebb

Ki vehet részt

  • SCI (AIS C or D in inpatient setting, AIS B-D in outpatient setting; inclusive of cervical injuries)
  • inpatients who are preambulatory with predicted probability of walking independently 1year after injury >50% (Hicks et al., 2017)
  • outpatients with a functional goal of improved locomotion where the XoMotion is clinically suited to support the achievement of their functional goals

Ki nem vehet részt

  • SCI AIS A

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

After spinal cord injury (SCI), many people lose their ability to walk and do not have access to equipment and assistance that could help them regain functional abilities. Furthermore, many who have the potential to regain function are further hindered by a loss of function in their upper body that limits their ability to use a walker or crutches, thus eliminating options for mobility.

A teljes eredeti leírásKevesebb

This study seeks to determine the safety and feasibility of the XoMotion-R, a self-balancing exoskeleton that allows people with American Spinal Injury Association Impairment Scale (AIS) rating of B-D SCI to walk hands-free in inpatient and outpatient settings. This study will examine how use of the XoMotion-R affects functional outcomes and identify setting-specific barriers and facilitators to clinical adoption.

This single-arm feasibility study will recruit 8 SCI inpatients and 8 SCI outpatients whose goal is to improve their walking and incorporate the XoMotion-R into their rehabilitation sessions. Participants will work on a variety of gait tasks tailored to their functional level. The goal is to determine whether early robotic gait training can improve functional outcomes and decrease length of stay, secondary complications, and long-term disability burden.

A vizsgálat 2 csoportja

  • Inpatient SCI GroupEgyéb csoport

    During their inpatient rehabilitation, the XoMotionR will be incorporated into their locomotor therapy program for approximately 30-45minutes, 2-3 times per week, up to 6 weeks. Inpatient intervention will be focused on promoting early weight-bearing, postural control, and initiation of step cycles. Training includes progressive walking tasks that emphasize symmetrical lower limb loading, upright posture, and engagement of trunk musculature. In addition to forward ambulation, sessions incorporate functional activities such as sit-to-stand transitions, pivot turns, and standing balance tasks which are all possible with the self-balancing XoMotion-R. The intervention is individualized based on tolerance, cardiovascular response, and patient progress, with adjustments made to walking speed, step length, and assistance levels over time.

    Kezelés: XoMotionR- assisted locomotor training

  • Outpatient SCI GroupEgyéb csoport

    Through our Specialized Outpatient Rehabilitation Program or Research Lab in the Courage Centre, SCI outpatients will be recruited and the XoMotionR will be incorporated into their locomotor therapy program for approximately 30-45minutes, 2-3 times per week, up to 6 weeks. Outpatient intervention will follow a task-specific approach emphasizing increased walking distance, reduced exoskeleton assistance, and advancement toward community-based ambulation goals. In this phase, the focus shifts toward higher-level gait tasks, including multi-surface walking, obstacle negotiation, and endurance training. Individuals are encouraged to use assistive devices with progressively less support as their neuromuscular control improves.

    Kezelés: XoMotionR- assisted locomotor training

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Adoption of the Xo-Motion R in the Subacute and Chronic SCI Populations at the Glenrose Rehabilitation Hospital
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. szeptember 16.